Quebec City, Quebec, March 31, 2015 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) announces that its common shares began trading under the ticker symbol “OPSSF” on the OTCQX marketplace in the United States, effective today. OTCQX, operated by OTC Markets Group Inc., offers the best informed and most efficient trading for established, global and growth companies. Opsens’ shares will continue trading on the TSX Venture Exchange under the ticker symbol “OPS.”
“The trading of Opsens’ shares in the U.S. will significantly increase our visibility among institutional and individual American investors. The size of the U.S. investor base specialized in medical instrumentation, and Opsens’ progress on the regulatory aspects leading to the commercialization of its FFR products in the United States are factors that motivate our decision to offer American investors the opportunity to invest in the Company prior to a significant growth phase,” said Louis Laflamme, President and CEO of Opsens.
Investors can find financial information and up-to-date public documents as well as real-time Level 2 quotes on Opsens at www.otcmarkets.com. As Principal American Liaison (“PAL”) for Opsens on OTCQX, Dorsey & Whitney LLP will provide professional guidance on OTCQX requirements as well as securities laws in the United States.
About Opsens Inc. (www.opsens.com or opsensmedical.com)
Opsens focuses mainly on two large and growing markets: interventional cardiology with a focus on Fractional Flow Reserve (“FFR”) and the industrial, oil and gas segment. In interventional cardiology, Opsens offers an advanced optical-based pressure guidewire (OptoWire) that aims at improving the clinical outcome of patients with coronary artery disease. In the industrial, oil & gas segment, Opsens develops, manufactures and installs innovative fibre optic sensing solutions for critical applications such as the monitoring of oil wells and other demanding industrial applications.
Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Thierry Dumas, CPA, CA, Chief Financial Officer, 418.682.9996
Louis Laflamme, CPA, CA, President and Chief Executive Officer, 418.682.9996